155 related articles for article (PubMed ID: 38310615)
1. Spheroid architecture strongly enhances miR-221/222 expression and promotes oxidative phosphorylation in an ovarian cancer cell line through a mechanism that includes restriction of miR-9 expression.
Ward AS; Hall CN; Tree MO; Kohtz DS
Mol Biol Rep; 2024 Feb; 51(1):275. PubMed ID: 38310615
[TBL] [Abstract][Full Text] [Related]
2. miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
Pan Y; Robertson G; Pedersen L; Lim E; Hernandez-Herrera A; Rowat AC; Patil SL; Chan CK; Wen Y; Zhang X; Basu-Roy U; Mansukhani A; Chu A; Sipahimalani P; Bowlby R; Brooks D; Thiessen N; Coarfa C; Ma Y; Moore RA; Schein JE; Mungall AJ; Liu J; Pecot CV; Sood AK; Jones SJ; Marra MA; Gunaratne PH
Oncotarget; 2016 May; 7(18):25930-48. PubMed ID: 27036018
[TBL] [Abstract][Full Text] [Related]
3. A novel p70 S6 kinase-microRNA biogenesis axis mediates multicellular spheroid formation in ovarian cancer progression.
Lam SS; Ip CK; Mak AS; Wong AS
Oncotarget; 2016 Jun; 7(25):38064-38077. PubMed ID: 27191261
[TBL] [Abstract][Full Text] [Related]
4. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
[TBL] [Abstract][Full Text] [Related]
5. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.
Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line.
Nam EJ; Lee M; Yim GW; Kim JH; Kim S; Kim SW; Kim YT
BMC Med Genomics; 2012 May; 5():18. PubMed ID: 22643117
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-21-5p in colorectal cancer cells promotes self-assembly of E-cadherin-dependent multicellular tumor spheroids.
Li A; Yang PM
Tissue Cell; 2020 Aug; 65():101365. PubMed ID: 32746985
[TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer.
Ding Y; Labitzky V; Legler K; Qi M; Schumacher U; Schmalfeldt B; Stürken C; Oliveira-Ferrer L
Mol Oncol; 2021 Dec; 15(12):3578-3595. PubMed ID: 34060699
[TBL] [Abstract][Full Text] [Related]
9. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
[TBL] [Abstract][Full Text] [Related]
10. The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.
Chen MW; Yang ST; Chien MH; Hua KT; Wu CJ; Hsiao SM; Lin H; Hsiao M; Su JL; Wei LH
Cancer Res; 2017 Apr; 77(8):1955-1967. PubMed ID: 28209618
[TBL] [Abstract][Full Text] [Related]
11. An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.
Pettee KM; Dvorak KM; Nestor-Kalinoski AL; Eisenmann KM
PLoS One; 2014; 9(2):e90371. PubMed ID: 24587343
[TBL] [Abstract][Full Text] [Related]
12. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.
Desjardins M; Xie J; Gurler H; Muralidhar GG; Sacks JD; Burdette JE; Barbolina MV
J Ovarian Res; 2014; 7():70. PubMed ID: 24999371
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination.
Klymenko Y; Johnson J; Bos B; Lombard R; Campbell L; Loughran E; Stack MS
Neoplasia; 2017 Jul; 19(7):549-563. PubMed ID: 28601643
[TBL] [Abstract][Full Text] [Related]
14. A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread.
Loessner D; Rizzi SC; Stok KS; Fuehrmann T; Hollier B; Magdolen V; Hutmacher DW; Clements JA
Biomaterials; 2013 Oct; 34(30):7389-400. PubMed ID: 23827191
[TBL] [Abstract][Full Text] [Related]
15. The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway.
Ogishima J; Taguchi A; Kawata A; Kawana K; Yoshida M; Yoshimatsu Y; Sato M; Nakamura H; Kawata Y; Nishijima A; Fujimoto A; Tomio K; Adachi K; Nagamatsu T; Oda K; Kiyono T; Osuga Y; Fujii T
BMC Cancer; 2018 Dec; 18(1):1201. PubMed ID: 30509235
[TBL] [Abstract][Full Text] [Related]
16. Wnt11 alters integrin and cadherin expression by ovarian cancer spheroids and inhibits tumorigenesis and metastasis.
Azimian-Zavareh V; Hossein G; Ebrahimi M; Dehghani-Ghobadi Z
Exp Cell Res; 2018 Aug; 369(1):90-104. PubMed ID: 29753625
[TBL] [Abstract][Full Text] [Related]
17. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration.
Gunay G; Kirit HA; Kamatar A; Baghdasaryan O; Hamsici S; Acar H
Gynecol Oncol; 2020 Nov; 159(2):563-572. PubMed ID: 32958270
[TBL] [Abstract][Full Text] [Related]
18. Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype.
Sodek KL; Ringuette MJ; Brown TJ
Int J Cancer; 2009 May; 124(9):2060-70. PubMed ID: 19132753
[TBL] [Abstract][Full Text] [Related]
19. miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation.
Salem M; Shan Y; Bernaudo S; Peng C
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013711
[TBL] [Abstract][Full Text] [Related]
20. p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation.
Ip CK; Yung S; Chan TM; Tsao SW; Wong AS
Oncotarget; 2014 Oct; 5(19):9133-49. PubMed ID: 25193855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
